Patent cliffs & loss of exclusivity
Apellis Pharmaceuticals is a biotechnology research company developing drug delivery technologies and therapeutics for the treatment of chronic inflammatory diseases.
| AngelList URL | https://angel.co/apellis-pharmaceuticals |
|---|---|
| CAGE Code | 5XS18 |
| Legal Name | Apellis Pharmaceuticals, Inc. |
| Company Operating Status | Active |
| Crunchbase URL | https://www.crunchbase.com/organization/apellis-pharmaceuticals |
| Full Address | 100 Fifth Ave, 3rd Floor, Waltham, MA 02451, US |
| LinkedIn URL | https://www.linkedin.com/company/apellis/ |
| Pitchbook URL | https://pitchbook.com/profiles/company/52771-51 |
Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.